bms.com Listed by apt73 Ransomware Group: Ransomware Claim — What’s Alleged & What To Do

On April 27, 2026, the ransomware group apt73 listed bms.com on its leak site and stated that internal files had been taken from the company. The number of people whose information may be involved is not known, and no further details about the scale or timing of the incident have been made public. Individuals connected to the listed files now face the possibility that personal information they provided to a pharmaceutical company has left its intended environment. When such data moves outside controlled systems, the main practical concerns are identity misuse, targeted fraud, or unwanted contact.

Breaking down the breach

The only confirmed public information is the listing itself. apt73 posted bms.com on its site and described the material as internal files obtained during a ransomware operation. The listing refers to personal data contained in 302 lines. No independent confirmation of the volume, the date of the intrusion, or the method of access has been released. The number of individuals affected is recorded as unknown.

Inside apt73

apt73 is a ransomware group that maintains a public leak site where it lists organisations it claims to have targeted. Groups of this type typically gain initial access through common vectors such as compromised credentials or unpatched systems, then move laterally to locate and copy data before deploying encryption. The listing of bms.com follows the pattern the group has used with other claimed victims: a short announcement accompanied by an assertion that files were removed. No additional statements from apt73 about the contents of the bms.com material have been published beyond the reference to 302 lines of personal data.

About bms.com

bms.com operates in the pharmaceutical sector. Companies in this field routinely collect and store records that include patient information, clinical trial data, employee details, and commercial documents. Because these records often contain health-related or financial identifiers, any unauthorised movement of files can affect both individuals and the organisation’s regulatory obligations.

What was likely exposed

The listing states that internal files were exfiltrated and that the material includes personal data appearing in 302 lines. No further breakdown of the fields or record types has been supplied. Pharmaceutical organisations commonly hold names, contact details, dates of birth, medical identifiers, and employment information, yet the precise contents of the 302 lines remain unconfirmed.

Why it matters

Personal data held by pharmaceutical companies can include sensitive health or financial details. If those details are no longer under the company’s control, affected people may experience increased attempts at account takeover, insurance fraud, or phishing that references their medical history. For the organisation, the incident adds to the regulatory and operational workload of assessing what was taken and notifying relevant authorities where required.

If your data was in this claimed breach

Begin by watching statements from bms.com for any official notification. Review recent account activity at banks, insurers, and healthcare portals, and enable multi-factor authentication where it is not already active. A free exposure scan of your email address against known breach data can show whether your information has appeared in other public listings.

AICompiled with AI assistance from public sources and published under our editorial standards.